Citation Impact
Citing Papers
p21/WAF1 expression as related to p53, cell proliferation and prognosis in epithelial ovarian cancer
1999
Metastasis-associated differences in gene expression in a murine model of osteosarcoma.
2001
HER-2 overexpression is an independent marker of poor prognosis of advanced primary ovarian carcinoma: a multicenter study of the GINECO group
2003
BCL-2 family protein expression and platinum drug resistance in ovarian carcinoma
2000
Biochemical and Molecular Mechanisms of Cisplatin Resistance
2002
The vaginal radical trachelectomy: An update of a series of 125 cases and 106 pregnancies
2011
The p53 Tumor Suppressor Gene: From Molecular Biology to Clinical Investigation
2000
Cisplatin: mode of cytotoxic action and molecular basis of resistance
2003 Standout
Cisplatin nephrotoxicity: Mechanisms and renoprotective strategies
2008 Standout
Surgery Insight: radical vaginal trachelectomy as a method of fertility preservation for cervical cancer
2007
Trends in Squamous Cell Carcinoma of the Vulva: The Influence of Vulvar Intraepithelial Neoplasia
1997
p53, the Cellular Gatekeeper for Growth and Division
1997 Standout
The relationship between cisplatin-induced reactive oxygen species, glutathione, and BCL-2 and resistance to cisplatin
2010
Cancer Statistics, 2006
2006 Standout
Synthesis, characterization and X-ray structures of new antiproliferative and proapoptotic natural aldehyde thiosemicarbazones and their nickel(II) and copper(II) complexes
2002
Adenosine receptors as therapeutic targets
2006 Standout
Molecular mechanisms of resistance and toxicity associated with platinating agents
2006 Standout
Involvement of reactive oxygen species and caspase 3 activation in arsenite-induced apoptosis
1998 Standout
Vulvar Intraepithelial Neoplasia
2005
Vaccination against HPV-16 Oncoproteins for Vulvar Intraepithelial Neoplasia
2009
HSP90 and the chaperoning of cancer
2005 Standout
ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents
1997
Anti-proliferative activity and mechanism of action of titanocene dichloride
1998
Conservative management of early stage cervical cancer: Is there a role for less radical surgery?
2011
Quadrivalent Vaccine against Human Papillomavirus to Prevent Anogenital Diseases
2007 Standout
Molecular mechanisms of platinum resistance: still searching for the Achilles? heel
2004
The biochemistry of apoptosis
2000 StandoutNature
Exploiting the PI3K/AKT Pathway for Cancer Drug Discovery
2005 Standout
Molecular mechanisms of cisplatin resistance
2011 Standout
Expression of the p53 tumour suppressor gene as a prognostic marker in platinum-treated patients with ovarian cancer
1998
Vaginal radical trachelectomy: A valuable fertility-preserving option in the management of early-stage cervical cancer. A series of 50 pregnancies and review of the literature
2005
Thermal ablation of tumours: biological mechanisms and advances in therapy
2014 Standout
Cellular and molecular determinants of cisplatin resistance
1998
The relationship between BcI2, Bax and p53: consequences for cell cycle progression and cell death
1998
DNA Polymerase δ Is Required for Human Mismatch Repair in Vitro
1997 StandoutNobel
p21 in cancer: intricate networks and multiple activities
2009 Standout
Four deaths and a funeral: from caspases to alternative mechanisms
2001 Standout
Cellular processing of platinum anticancer drugs
2005 Standout
Hsp70 chaperones: Cellular functions and molecular mechanism
2005 Standout
Targeting apoptosis in cancer therapy
2020 Standout
Cisplatin resistance and oncogenes - a review
2000
Human papillomavirus and cervical cancer
2007 Standout
Ovarian cancer: Patterns of surgical care across the United States
2006
Oncological outcomes after fertility-sparing surgery for cervical cancer: a systematic review
2016
Combined modality radioimmunotherapy
2002
Photodynamic therapy and anti-tumour immunity
2006 Standout
Alteration in p53 pathway and defect in apoptosis contribute independently to cisplatin-resistance
1998
Live or let die: the cell's response to p53
2002 Standout
Progress and problems with the use of viral vectors for gene therapy
2003 Standout
Cancer immunotherapy comes of age
2011 StandoutNature
Tumor necrosis factor signaling
2003 Standout
Photodynamic therapy of cancer: An update
2011 Standout
Synergistic cytotoxic action of cisplatin and withaferin A on ovarian cancer cell lines
2012
Cisplatin and Adriamycin Resistance Are Associated with MutLα and Mismatch Repair Deficiency in an Ovarian Tumor Cell Line
1996 StandoutNobel
Cisplatin in cancer therapy: Molecular mechanisms of action
2014 Standout
Immunotherapy of Diffuse Gliomas: Biological Background, Current Status and Future Developments
2009 Standout
Is Cisplatin-Induced Cell Death Always Produced by Apoptosis?
2001
Tumor Hypoxia: Definitions and Current Clinical, Biologic, and Molecular Aspects
2001 Standout
Synthesis, characterisation and biological activity of three copper(II) complexes with a modified nitrogenous base: 5-formyluracil thiosemicarbazone
1998
Escaping Cell Death: Survival Proteins in Cancer
1999
Apoptosis induced by cryo‐injury in human colorectal cancer cells is associated with mitochondrial dysfunction
2002
The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis
2004 Standout
Cervical cancer
2019 Standout
Clinical Perspectives on Platinum Resistance
2000
Osmotic Diuretics Induce Adenosine A1 Receptor Expression and Protect Renal Proximal Tubular Epithelial Cells against Cisplatin-mediated Apoptosis
2004
The first 30 years of p53: growing ever more complex
2009 Standout
Mechanisms of resistance to cisplatin
2001
Head and Neck Cancer
2001 Standout
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Biochemical Modulation of Cisplatin Mechanisms of Action: Enhancement of Antitumor Activity and Circumvention of Drug Resistance
2003 Standout
Bonding and structure trends of thiosemicarbazone derivatives of metals—An overview
2008 Standout
A Mutant p53 That Discriminates between p53-Responsive Genes Cannot Induce Apoptosis
1996
Overexpression of long non-coding RNA PVT1 in ovarian cancer cells promotes cisplatin resistance by regulating apoptotic pathways.
2015
Long Noncoding RNA and Cancer: A New Paradigm
2017 Standout
Organometallic Anticancer Compounds
2010 Standout
Apoptosis and the Dilemma of Cancer Chemotherapy
1997
Replication of ONYX-015, a Potential Anticancer Adenovirus, Is Independent of p53 Status in Tumor Cells
1998 StandoutNobel
Human MutSalpha recognizes damaged DNA base pairs containing O6-methylguanine, O4-methylthymine, or the cisplatin-d(GpG) adduct.
1996 StandoutNobel
Selective replication and oncolysis in p53 mutant tumors with ONYX-015, an E1B-55kD gene-deleted adenovirus, in patients with advanced head and neck cancer: a phase II trial.
2000
Microsatellite instability, apoptosis, and loss of p53 function in drug-resistant tumor cells.
1996
Enhanced Bone Regeneration Associated With Decreased Apoptosis in Mice With Partial HIF-1α Deficiency
2006 StandoutNobel
Tumor Microsatellite-Instability Status as a Predictor of Benefit from Fluorouracil-Based Adjuvant Chemotherapy for Colon Cancer
2003 Standout
CD40 Induces Apoptosis in Carcinoma Cells through Activation of Cytotoxic Ligands of the Tumor Necrosis Factor Superfamily
2000
Human Papillomavirus and Cervical Cancer
2003 Standout
cis -Diammine(pyridine)chloroplatinum(II), a monofunctional platinum(II) antitumor agent: Uptake, structure, function, and prospects
2008 StandoutNobel
SYNERGISTIC ENHANCEMENT OF RESISTANCE TO CISPLATIN IN HUMAN BLADDER CANCER CELLS BY OVEREXPRESSION OF MUTANT-TYPE p53 AND Bcl-2
1999
Structure, Recognition, and Processing of Cisplatin−DNA Adducts
1999 Standout
Ultrafast Dynamics of Flavins in Five Redox States
2008 StandoutNobel
Mechanisms of Diabetic Complications
2013 Standout
Advances in Copper Complexes as Anticancer Agents
2013 Standout
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
AKT/PKB signaling mechanisms in cancer and chemoresistance
2005
Cytokeratin-18 Is a Useful Serum Biomarker for Early Determination of Response of Breast Carcinomas to Chemotherapy
2007
Immunological and viral factors associated with the response of vulval intraepithelial neoplasia to photodynamic therapy.
2001
Works of J. Herod being referenced
Vulvar intraepithelial neoplasia with superficially invasive carcinoma of the vulva
1996
The development of invasive vulvar cancer in a patient with Job's syndrome, a rare immunodeficient condition
1998
Vulvar intraepithelial neoplasia: long term follow up of treated and untreated women
1996
Radical vaginal trachelectomy as a fertility‐sparing procedure in women with early‐stage cervical cancer—cumulative pregnancy rate in a series of 123 women
2006
Placement of a Malecot catheter to enable embryo transfer after radical trachelectomy
2005
Actinomyces on a papanicolaou smear following a radical trachelectomy
2003
The prognostic significance of Bcl-2 and p53 expression in ovarian carcinoma.
1996
The control of apoptosis and drug resistance in ovarian cancer: influence of p53 and Bcl-2.
1995